Evaluation of potential infectivity of Alzheimer and Parkinson disease proteins in recipients of cadaver-derived human growth hormone.
about
Evidence for human transmission of amyloid-β pathology and cerebral amyloid angiopathyCalcium-Sensing Receptors of Human Neural Cells Play Crucial Roles in Alzheimer's DiseaseThe amyloid hypothesis of Alzheimer's disease at 25 yearsInsights into Mechanisms of Chronic NeurodegenerationSelf-propagation of pathogenic protein aggregates in neurodegenerative diseasesNeurodegenerative diseases: expanding the prion conceptParkinson's disease dementia: convergence of α-synuclein, tau and amyloid-β pathologies.Spreading of pathology in neurodegenerative diseases: a focus on human studiesAlpha-synuclein spreading in Parkinson's diseaseThe use of cerebrospinal fluid and neuropathologic studies in neuropsychiatry practice and researchAlpha-synuclein and tau: teammates in neurodegeneration?Alzheimer Disease and Its Growing Epidemic: Risk Factors, Biomarkers, and the Urgent Need for Therapeutics.Profoundly different prion diseases in knock-in mice carrying single PrP codon substitutions associated with human diseases.Aβ seeds resist inactivation by formaldehydePropagation of tau pathology: hypotheses, discoveries, and yet unresolved questions from experimental and human brain studies.Biology and genetics of prions causing neurodegenerationBrains from non-Alzheimer's individuals containing amyloid deposits accelerate Aβ deposition in vivoIs there a risk of prion-like disease transmission by Alzheimer- or Parkinson-associated protein particles?Transfer of human α-synuclein from the olfactory bulb to interconnected brain regions in mice.Frontotemporal lobar degeneration: defining phenotypic diversity through personalized medicine.Comparative Incidence of Conformational, Neurodegenerative Disorders.α-Synuclein and nonhuman primate models of Parkinson's diseaseTargeting protein aggregation for the treatment of degenerative diseasesTransport of cargo from periphery to brain by circulating monocytes.Tauopathies as clinicopathological entities.Dura mater is a potential source of Aβ seeds.Etiologic Framework for the Study of Neurodegenerative Disorders as Well as Vascular and Metabolic Comorbidities on the Grounds of Shared Epidemiologic and Biologic FeaturesAn Efficient Procedure for Removal and Inactivation of Alpha-Synuclein Assemblies from Laboratory Materials.Drivers: A Biologically Contextualized, Cross-Inferential View of the Epidemiology of Neurodegenerative Disorders.PrP aggregation can be seeded by pre-formed recombinant PrP amyloid fibrils without the replication of infectious prionsCan Creutzfeldt-Jakob disease unravel the mysteries of Alzheimer?From soluble aβ to progressive aβ aggregation: could prion-like templated misfolding play a role?Convergence of synapses, endosomes, and prions in the biology of neurodegenerative diseases.Prion-like activity of Cu/Zn superoxide dismutase: implications for amyotrophic lateral sclerosis.Cell-to-cell transmission of pathogenic proteins in neurodegenerative diseases.β-Amyloid peptides and amyloid plaques in Alzheimer's disease.Is Parkinson's disease truly a prion-like disorder? An appraisal of current evidence.Mini review: linkage between α-Synuclein protein and cognition.TDP-43 in amyotrophic lateral sclerosis - is it a prion disease?Propagation of Aß pathology: hypotheses, discoveries, and yet unresolved questions from experimental and human brain studies.
P2860
Q22251077-7B0EB8CC-BDAC-4D93-8D3B-4BE761490BD4Q26747527-0F2A126B-BD3A-456B-A8E0-4C6B3B95BDB3Q26749528-0E117703-665B-49F0-A432-E19D820A5E31Q26771732-C9F0A8D7-AB36-4240-8366-A0B7F86C93BFQ26996441-7437D491-7A78-4867-A79E-BD488BE457C3Q27011744-C4B0E7FF-E80B-4B0C-B6AB-DF5E9FA5B7BFQ27686837-14715C98-4B45-4AA8-BE94-016AC957ADE3Q28082279-9446A5AA-9590-4823-B963-8557F5309E45Q28082548-68101249-E012-4548-8C77-AB325ACBF310Q28088291-8476F1A4-12CA-4D08-9D8F-5A87BC984060Q28250508-A2DCC85C-60C2-43BD-B0F8-F62CCDEC5FB0Q30244736-1B49B52B-1F8E-4A2E-B106-34B663DAACB1Q30544329-93E83974-A372-4D93-845B-F8F565FF1ACBQ30587263-D1A8F6F1-8B9C-4667-ACAB-3ABB12C64B9DQ31024674-79D9A7A8-C3F5-4A9B-8009-CE5CB4256F40Q33567229-7EAFDD01-C3E2-407E-90F2-2AC1D20308B8Q33715557-E6A641DE-B8AA-4266-B0E5-67F090453CCAQ34157427-BC987188-A3E0-4AE5-BA1B-55023BBD5846Q34909750-EEB89FF7-5DC4-44B1-A5C3-3D040187D703Q35204586-B0A10010-8CA4-46C9-B9DA-27A06083E70EQ35763399-64E01401-A67E-42FF-B0C3-F29BE43361C9Q36157306-5DF26C96-F524-4F4E-B709-F35ABD2C4D23Q36235980-FA2FDAA5-3B65-4078-9804-124801826ACFQ36274153-55239857-654B-4F58-A44D-5D96EE0BB5BEQ36326790-087C46B5-4758-4DB9-9CE1-2BE7F4AB87CBQ36896989-3E459B79-F13E-4A88-B378-5DDC5F981765Q36995708-C7E9C733-1234-4681-B409-A70D4A7E536AQ37053806-069011F1-B8D7-4465-AD90-8CB0CFBA17B4Q37053839-FB5278FD-0F24-451E-A92D-893F75D9B658Q37256565-BEB745AF-00F5-49BC-98DD-0BB61025C9DFQ37409402-EEBED9FC-C19E-4F25-B995-8A6E835BB42CQ38099070-417AD3E0-7092-4D67-B8BA-D5180C0AF931Q38168833-94C762BE-5AE3-4481-96C9-BB20295BE70FQ38176187-F3BCEF49-4345-4B12-8D96-C064AF2FCBF0Q38185934-084040AB-0F8A-4523-BD65-38AE99CF595BQ38265124-3B47EFCC-48FC-4914-BA07-6613A2556E6AQ38344903-780710E5-F0DB-420E-A633-0B9B42C171FFQ38401326-4DB1E3B8-62FA-4736-946D-F91B096309B2Q38407804-68A3ED5B-08A8-4939-863A-7B8E5A6E824AQ38682621-F917B6A7-742B-4BBF-BF6E-EF50E77CC32F
P2860
Evaluation of potential infectivity of Alzheimer and Parkinson disease proteins in recipients of cadaver-derived human growth hormone.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Evaluation of potential infect ...... -derived human growth hormone.
@en
type
label
Evaluation of potential infect ...... -derived human growth hormone.
@en
prefLabel
Evaluation of potential infect ...... -derived human growth hormone.
@en
P2093
P2860
P1433
P1476
Evaluation of potential infect ...... -derived human growth hormone.
@en
P2093
David J Irwin
Ellen Werber Leschek
James L Mills
Joseph Y Abrams
Lawrence B Schonberger
Virginia M-Y Lee
P2860
P304
P356
10.1001/JAMANEUROL.2013.1933
P407
P577
2013-04-01T00:00:00Z